InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by ARCH Venture Fund XI, L.P.. Director active across 1 companies, notably DA32 Life Science Tech Acquisition Corp.. Cumulatively, 2 reports have been logged. Total volume traded: €26.9m. The latest transaction was filed on 30 July 2021 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€13m1,600,000 shares@ €8.4083100.0% of flow
Class A Common Stock
SEC:0000899243-21-031417·
Ideal exit: 26 Apr 2022 (T+270)
€13m1,600,000 shares@ €8.408350.0% of flow
Class A Common Stock
SEC:0000899243-21-031417:0·
Ideal exit: 26 Apr 2022 (T+270)
2 of 2 declarations
